Studieoverzicht
Study name: TBPETCT001
Histology | NSCLC, SCLC | ||
---|---|---|---|
Tumor stage | Stage I - III, Stage III - IV | ||
Host / recruiting site 1 | Amsterdam UMC | Enrollment | Recruiting |
Design |
A mono-center exploratory study to explore new imaging procedures with an ultra-high sensitivity total body PET-CT system |
||
Intervention | No interventions / treatments other than for routine patient care will be performed as part of this protocol |
||
Key outcome parameters | Determination of imaging procedures that are optimized in relation to the high sensitivity and the large anatomical coverage of a total body PET-CT systems and with similar or better lesion detectability as compared to standard procedures. |
||
Key inclusion criteria | Adults (18-64 years) Able to give consent Signed informed consent Patients who have an indication for a standard FDG PET-CT scan For sub-study 2 (breath hold PET), patients with NSCLC, stage 2 or higher : sub-study is closed |
||
Key exclusion criteria | Claustrophobic patients Pregnant or breastfeeding woman Uncontrolled diabetes mellitus Any medical condition potentially hampering conduction of the study Any other contraindication to undergo an FDG PET-CT examination |
||
Contact information | Log in voor de contactinformatie |